Medical Science Liaison (Mid-Atlantic)

Overview

Entrepreneurial Spirit, Rooted in Tradition. Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) in Japan, which touts a storied reputation more than 300 years in the making. Our parent company - one of Japan’s most respected - is a research-driven pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines for serious diseases, including multiple sclerosis (MS), diabetes mellitus (DM), amyotrophic lateral sclerosis (ALS), and is currently developing medicines in  Neurology in Parkinson’s (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology.

MTPA is rapidly expanding its operations across all functional areas. MTPA’s commitment to patients and their communities continues with a robust late-stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets.  In the United States, MTPA launched rare disease treatments including RADICAVA® (edaravone) injectables in 2017 and RADICAVA® (edaravone) oral suspension in 2022.  The company handles research, clinical development, sales, marketing, medical affairs, supply chain, and business development functions.  MTPA is dedicated to improving the treatment environment for those with debilitating diseases, researching on real-world evidence, and creating hope for all facing illness. 

The Medical Science Liaison (MSL) provides a vital role to the organization by bridging internal strategy with external medical insights. Through field interactions with the healthcare community, the Medical Science Liaison supports disease awareness activities within assigned field territory, participates in scientific exchange, and obtains valuable information regarding unmet medical needs and current treatment paradigms to help guide executive decisions. As part of an emerging US and global organization, the Medical ScienceLiaison will also make significant contributions to processes, procedures, and best practices within the developing organization, serve as a medical resource to healthcare providers, clinical investigators and clinical study sites, and healthcare decision makers regarding the organization’s investigational and marketed products, and support product commercialization. The Medical Science Liaison will spend the majority of their time in the field developing and maintaining scientific relationships with Healthcare Providers.

Responsibilities

• Develop enduring professional relationships with healthcare practitioners, clinical investigators, and healthcare decision makers within assigned territory, to provide medical and scientific support for selected therapeutic areas and to ensure access to current medical and scientific information on Mitsubishi Tanabe Pharma America’s (MTPA’s) products and areas of therapeutic interest.
• Gather insights regarding unmet medical needs and treatment landscapes in targeted therapeutic areas.
• Attend and support scientific and medical meetings. Disseminate clinical and competitive insights within the organization and prepare post-meeting deliverables as needed.
• Respond to unsolicited requests; provide truthful, non-misleading and non-promotional information regarding MTPA’s commercial and pipeline products to healthcare professionals including physicians, hospital and MCO practitioners and formulary committees, pharmacists, nurse practitioners, physician assistants, dieticians and others.
• Assist in the development of educational materials and standard responses to frequently asked questions (FAQs); provide product-related site education; serve as medical resource for home office and field colleague training.
• Present information to healthcare professionals who provide peer education to assist in keeping their presentations current and ensure they have the medical and scientific information necessary to respond to questions encountered during their discussions.
• Support Phase 3, Phase 4, and Investigator Sponsored Trials (ISTs) as needed.
• Ensure that all medical education activities are conducted in full compliance with relevant guidance, rules and regulations.
• Depending on organizational needs, the Medical Science Liaison may also be asked to:
  • Support medical initiatives across other therapeutic areas relevant to licensing, translational, and clinical development activities.
  • Collaborate with colleagues from sister and parent companies to support product development activities, including identification and support of clinical investigators and clinical study sites.
• Complete all company and job related training as assigned within the required timelines.